Literature DB >> 15987638

Parkin interacts with the proteasome subunit alpha4.

J C Dächsel1, C B Lücking, S Deeg, E Schultz, M Lalowski, E Casademunt, O Corti, C Hampe, N Patenge, K Vaupel, A Yamamoto, M Dichgans, A Brice, E E Wanker, P J Kahle, T Gasser.   

Abstract

Mutations in the parkin gene encoding an E3 ligase are responsible for autosomal recessive Parkinson's disease. Putative parkin substrates and interacting partners have been identified, but the molecular mechanism underlying parkin-related neurodegeneration is still unclear. We have identified the 20S proteasomal subunit alpha4 (synonyms: PSMA7, XAPC7, subunit alpha type 7) as a new interacting partner of parkin. The C-terminal IBR-RING domain of parkin and the C-terminal part of alpha4 were essential for the interaction. Biochemical studies revealed that alpha4 was not a substrate for parkin-dependent ubiquitylation. Putative functions of the interaction might therefore be substrate presentation to the proteasome or regulation of proteasomal activity. Full-length parkin and parkin lacking the N-terminal ubiquitin-like domain slightly increased the proteasomal activity in HEK 293T cells, in line with the latter hypothesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987638     DOI: 10.1016/j.febslet.2005.06.003

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Mdm2 facilitates the association of p53 with the proteasome.

Authors:  Roman Kulikov; Justine Letienne; Manjit Kaur; Steven R Grossman; Janine Arts; Christine Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

2.  Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.

Authors:  Hsin F Chien; Christan F Rohé; Maria D L Costa; Guido J Breedveld; Ben A Oostra; Egberto R Barbosa; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2005-11-22       Impact factor: 2.660

3.  Polymorphisms in the proteasomal subunit alpha4 are not associated with Parkinson's disease.

Authors:  C B Lücking; P Lichtner; M Dichgans; T Illig; C Gieger; D Berg; T Gasser
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

4.  The E3 ubiquitin ligase parkin is recruited to the 26 S proteasome via the proteasomal ubiquitin receptor Rpn13.

Authors:  Miguel A Aguileta; Jelena Korac; Thomas M Durcan; Jean-François Trempe; Michael Haber; Kalle Gehring; Suzanne Elsasser; Oliver Waidmann; Edward A Fon; Koraljka Husnjak
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

5.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

6.  Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition.

Authors:  Guomei Tang; Ming D Perng; Sherwin Wilk; Roy Quinlan; James E Goldman
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

7.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

8.  Parkin, A Top Level Manager in the Cell's Sanitation Department.

Authors:  Carolyn A Rankin; Ambrish Roy; Yang Zhang; Mark Richter
Journal:  Open Biochem J       Date:  2011-04-18

9.  Parkin occurs in a stable, non-covalent, approximately 110-kDa complex in brain.

Authors:  Cindy Van Humbeeck; Etienne Waelkens; Olga Corti; Alexis Brice; Wim Vandenberghe
Journal:  Eur J Neurosci       Date:  2008-01-08       Impact factor: 3.386

Review 10.  RBR E3 ubiquitin ligases: new structures, new insights, new questions.

Authors:  Donald E Spratt; Helen Walden; Gary S Shaw
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.